tamibarotene
Showing 1 - 8 of 8
Chronic Myelomonocytic Leukemia Trial in Houston (Azacitidine, Tamibarotene, Venetoclax)
Not yet recruiting
- Chronic Myelomonocytic Leukemia
- Azacitidine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 10, 2023
Acute Myeloid Leukemia Trial in United States (Tamibarotene, Venetoclax, Azacitidine)
Recruiting
- Acute Myeloid Leukemia
- Tamibarotene
- +2 more
-
Duarte, California
- +7 more
Mar 27, 2022
Acute Promyelocytic Leukemia Trial in Chicago (Tamibarotene, Arsenic trioxide)
Terminated
- Acute Promyelocytic Leukemia
- Tamibarotene
- Arsenic trioxide
-
Chicago, IllinoisNorthwestern University
Oct 28, 2013
Stage IIIB NSCLC With Pleural Effusion, Stage IV NSCLC Trial in Worldwide (Tamibarotene, Placebo)
Terminated
- Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion
- Stage IV Non-small Cell Lung Cancer
- Tamibarotene
- Placebo
-
Rancho Mirage, California
- +25 more
Jun 27, 2013
Acute Promyelocytic Leukemia Trial in Chicago, Houston (Tamibarotene)
Completed
- Acute Promyelocytic Leukemia
- Tamibarotene
-
Chicago, Illinois
- +1 more
Feb 11, 2013
Lupus Nephritis Trial in Osaka (Tamibarotene)
Unknown status
- Lupus Nephritis
- Tamibarotene
-
Osaka, JapanKinki University Hospital
Jul 21, 2011
Alzheimer's Disease Trial in Osaka (Tamibarotene, Placebo)
Unknown status
- Alzheimer's Disease
- Tamibarotene
- Placebo
-
Osaka, JapanOsaka City University Hospital
Jul 21, 2011
HTLV-I-Associated Myelopathy Trial in Kanagawa (Tamibarotene)
Unknown status
- HTLV-I-Associated Myelopathy
- Tamibarotene
-
Kanagawa, JapanIseikai Medical Corporation, Shoyo Kashiwadai Hospital
Jul 21, 2011